A new way to finance drug development, for rare disease and beyond | Talking Precision Medicine #28
11/30/2022
0:00
45:36
In this episode, our host and Genialis CEO Rafael Rosengarten spotlights Vibe Bio. Vibe Bio is a new biotech aiming to disrupt how we finance drug development through stakeholder communities and cryptocurrency, starting in the rare disease arena. Our guest is Alok Tayi, co-founder and CEO of Vibe. Alok is a successful serial entrepreneur and a rare disease community member.
Visit TPM E28 for highlights and links from this episode.
More episodes from "Talking Precision Medicine"
Don't miss an episode of “Talking Precision Medicine” and subscribe to it in the GetPodcast app.